NASDAQ:VASC Vascular Solutions (VASC) Stock Price, News & Analysis → The 1,000X Crypto Playbook (From True Market Insiders) (Ad) Free VASC Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range$56.00▼$56.0050-Day Range N/A52-Week Range$25.06▼$57.15VolumeN/AAverage Volume248,891 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Vascular Solutions alerts: Email Address Ad Weiss RatingsThe ONE AI Stock to own now. (It’s not Nvidia.)Don’t panic — you haven’t missed the boat on AI. In fact, it has barely launched. Sure, the early stages of this boom were big … But I believe the real wealth in AI has yet to be made …Click here to see the presentation now. About Vascular Solutions Stock (NASDAQ:VASC)Vascular Solutions, Inc. is a medical device company focused on bringing clinically advanced solutions to the market for treating coronary and peripheral vascular disease. The Company's product line consists of devices and services that are sold to interventional cardiologists, interventional radiologists, electrophysiologists and vein practices around the world. Its products include GuideLiner catheters, Pronto catheters, Vein catheter reprocessing, Micro-introducer kits, Hemostatic patches, Radial access products, Langston catheters and D-Stat Flowable hemostat. The Company's product portfolio includes a spectrum of over 90 products consisting of approximately 900 stock keeping units (SKUs) covering an array of blood clotting devices, extraction catheters, access catheters, guide extension catheters, micro-introducer kits, guidewires, snare and retrieval devices, a reprocessing service for radiofrequency catheters and a laser and procedure kits for the treatment of varicose veins.Read More Ad Weiss RatingsThe ONE AI Stock to own now. (It’s not Nvidia.)Don’t panic — you haven’t missed the boat on AI. In fact, it has barely launched. Sure, the early stages of this boom were big … But I believe the real wealth in AI has yet to be made …Click here to see the presentation now. VASC Stock News HeadlinesMay 16 at 4:51 PM | usnews.comBrain Decline, Dementia Common Among Older American IndiansMay 16 at 4:51 PM | msn.comCognitive decline rates higher among older Native AmericansMay 15 at 9:09 PM | msn.comOlder Native Americans may experience higher levels of cognitive impairment than previously thoughtMay 15 at 4:09 PM | finance.yahoo.comVarian Announces Exclusive US Distribution Agreement with Innova Vascular for New Innovative Thrombectomy SolutionsMay 13, 2024 | finance.yahoo.comNorth America Vascular Stents Market Set for Notable Growth, Expected to Reach US$ 5.8 Billion by 2032May 9, 2024 | msn.comNew fluidic system advances development of artificial blood vessels and biomedicine applicationsMay 8, 2024 | finance.yahoo.comInsider Sale: President and Director David Roberts Sells Shares of LeMaitre Vascular Inc (LMAT)May 6, 2024 | finance.yahoo.comRapidAI Secures FDA Clearance for Perfusion Imaging in the Angiography SuiteMay 3, 2024 | uk.finance.yahoo.comQ1 2024 LeMaitre Vascular Inc Earnings CallMay 2, 2024 | msn.comCoalition forming to oppose psychedelics ballot question, argues home-grow is unsafeApril 30, 2024 | finance.yahoo.com"A New Era in Venous Care: Bowie Welcomes Vein Treatment Clinic"April 26, 2024 | msn.comExercise can ease peripheral artery disease symptomsApril 25, 2024 | msn.comValcare Medical names CEO as part of restructuringApril 24, 2024 | finance.yahoo.comValcare Medical, Inc. Announces Corporate Restructuring and Appointment of New CEOApril 22, 2024 | finance.yahoo.comInnovative Aspiration Thrombectomy System by Expanse ICE Receives FDA Clearance for vessels of the peripheral arterial and venous systemsApril 20, 2024 | msn.com3 parks in N.J. city being investigated for high lead levelsApril 17, 2024 | finance.yahoo.comXeltis Announces Latest Results from aXess Trials to be Presented at 46th Annual Charing Cross SymposiumApril 17, 2024 | finance.yahoo.comCardiovascular Centers of America Announces Cardiac Ablation Service Line at Advanced Heart and Vascular in Deltona, FloridaApril 16, 2024 | msn.com3 Best Stocks to Buy Now, 4/16/2024, According to Top AnalystsApril 12, 2024 | finance.yahoo.comTri-City Cardiology's Ambulatory Surgical Center (ASC) Leads the Way in Revolutionizing Heart Failure ManagementApril 12, 2024 | msn.comBiofest propels San Antonio's economic growth while transforming global healthApril 12, 2024 | markets.businessinsider.comTridentCare to Expand Its Presence Across Commercial, Government and Home-Based Customer Markets - Appoints New Chief Growth OfficerApril 10, 2024 | uk.finance.yahoo.comGlobal Vascular Embolization Devices Market Report 2024: Compound Annual Growth of 6.69% Forecast During 2023-2028April 9, 2024 | finance.yahoo.comNew Study Shows Consistent Use of Goode Health's Ultimate Superfood Blend Results In Significant Health ImprovementsApril 8, 2024 | finance.yahoo.comRebound Medical Receives Growth Equity Investment from Castleford CapitalSee More Headlines Receive VASC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Vascular Solutions and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryHealth Care Supplies Current SymbolNASDAQ:VASC CUSIP92231M10 CIK1030206 Webvasc.com Phone+1-763-6564300FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report VASC Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Vascular Solutions own? Based on aggregate information from My MarketBeat watchlists, some companies that other Vascular Solutions investors own include Teleflex (TFX), Arrowhead Pharmaceuticals (ARWR), Tourmaline Oil (TOU), Ambarella (AMBA), Aralez Pharmaceuticals (ARLZ), Bausch Health Companies (BHC), Cardiovascular Systems (CSII) and 3D Systems (DDD). This page (NASDAQ:VASC) was last updated on 5/17/2024 by MarketBeat.com Staff From Our PartnersGold Set to EXPLODE!Gold Safe ExchangeHow Biden has already won 2024Porter & CompanyBiden Nomination CANCELED?The Freeport SocietyThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 Media348 million Americans lives to END as we know it?The Oxford ClubA once-in-a-century investment opportunityStansberry ResearchCharles Payne Demystifies OptionsUnstoppable ProsperityBiden FINISHED On June 13th?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vascular Solutions Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.